Adjuvant therapy and long-term management of differentiated thyroid carcinoma.
Semin Surg Oncol
; 16(1): 30-3, 1999.
Article
in En
| MEDLINE
| ID: mdl-9890737
ABSTRACT
As with most therapies for differentiated thyroid carcinoma, there is little consensus about optimal use of postoperative adjuvant therapies or long-term follow-up strategies. However, an increasing body of data indicates that most patients can benefit from postoperative radioiodine ablation followed by thyroid hormone suppression therapy. An approach to long-term monitoring and therapy is provided, including the use of strategies dependent upon the extent of the patient's initial disease.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Carcinoma
Limits:
Humans
Language:
En
Journal:
Semin Surg Oncol
Journal subject:
NEOPLASIAS
Year:
1999
Document type:
Article
Affiliation country:
Estados Unidos